Mark Cuban invests in dozens of companies, but he’s never put his own name on one before. That changed with Mark Cuban Cost Plus Drug Company. In this conversation, he tells LinkedIn’s Editor-in-Chief, Dan Roth, exactly why he wants to make commonly prescribed prescription drugs available as cheaply as he can, and what industries he thinks up-and-coming entrepreneurs should set their sights on.
Follow Mark Cuban on LinkedIn
Follow Daniel Roth on LinkedIn
Join our This is Working community by subscribing to Dan’s newsletter and posting your thoughts using the hashtag #ThisIsWorking.
